Nonviral liver disease is the leading indication for liver transplant in the United States in persons living with human immunodeficiency virus

29Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We evaluated whether indications for liver transplantation (LT) have changed among people with/without human immunodeficiency virus (HIV) infection and compared LT outcomes and trends by HIV serostatus. LT recipients (2008–2018) from the United Network for Organ Sharing and Organ Procurement and Transplantation Network (UNOS/OPTN) were identifed. Among 62 195 LT recipients, 352 (0.6%) were HIV-infected. The proportion of HIV-infected patients increased over time (P trend =.001), as did the number of transplant centers performing LT for HIV-infected recipients; average annual percentage change of 9.2% (p

Cite

CITATION STYLE

APA

Campos-Varela, I., Dodge, J. L., Terrault, N. A., Brandman, D., & Price, J. C. (2021). Nonviral liver disease is the leading indication for liver transplant in the United States in persons living with human immunodeficiency virus. American Journal of Transplantation, 21(9), 3148–3156. https://doi.org/10.1111/ajt.16569

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free